Drug intelligence / Profile preview

short ragweed allergenic extract

Development stage
Phase 2
Lead developer
ALK Abelló
Administration
Sublingual
01

Overview

Short ragweed allergenic extract is a biological product used for allergen-specific immunotherapy. It is derived from the pollen of *Ambrosia artemisiifolia* (short ragweed) and is administered to individuals sensitized to ragweed pollen to reduce allergic symptoms. The extract works by modulating the immune system, aiming to induce immune tolerance to ragweed allergens. This involves a shift from a T helper 2 (Th2) cell response to a T helper 1 (Th1) cell response, leading to decreased levels of interleukins IL-4 and IL-5, and increased production of IL-10. It also promotes the production of IgG-blocking antibodies that compete with IgE antibodies for allergen binding, stimulates the proliferation of regulatory T lymphocytes, and reduces the presence of mast cells and eosinophils. The product is standardized based on its Antigen E (Amb a 1) content, which is considered a primary allergen component.

Brand names
GREER SAIL
Other names
Standardized Allergenic Extract, Short Ragweed (Ambrosia artemisiifolia)Short Ragweed Pollen Allergenic Extract
02

Targets

TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on short ragweed allergenic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on short ragweed allergenic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call